AI Article Synopsis

  • The study aimed to assess cases of new or reactivated uveitis in patients receiving biologic therapy, focusing on their characteristics.* -
  • A multicenter review identified 16 patients with underlying conditions like ankylosing spondylitis and rheumatoid arthritis, who developed uveitis linked to biologic drugs such as etanercept and adalimumab.* -
  • Findings indicated that biologic agents often induce uveitis that manifests as granulomatous disease, with several patients showing signs consistent with sarcoid uveitis.*

Article Abstract

Purpose/objectives: to evaluate new onset uveitis or reactivated uveitis by biologic agents and characterize their features.

Materials And Methods: This is a multicenter, retrospective case series. Patients under biologic therapy were included if they developed uveitis for the first time or experienced intraocular inflammation which was different in location or laterality to previous inflammation.

Results: Sixteen patients were identified. The underlying disorders included ankylosing spondylitis, juvenile idiopathic arthritis, rheumatoid arthritis, and Behçet's Disease. The biologic agents associated with a first episode of uveitis (n = 11) or with a new recurrence of uveitis (n = 5) were etanercept, adalimumab, abatacept, infliximab, and golimumab. Sarcoidosis based on bihilar lymphadenopathy, other computer tomography-findings, or biopsy was diagnosed in five patients under therapy with etanercep, adalimumab, and abatacept. Additionally, seven patients developed clinical changes in their uveitis pattern, suggesting sarcoid uveitis.

Conclusions: Biologic treatment-induced uveitis often presents as granulomatous disease.

Download full-text PDF

Source
http://dx.doi.org/10.1080/09273948.2020.1850799DOI Listing

Publication Analysis

Top Keywords

uveitis
8
biologic agents
8
adalimumab abatacept
8
drug-induced sarcoid
4
sarcoid uveitis
4
uveitis biologics
4
biologics purpose/objectives
4
purpose/objectives evaluate
4
evaluate onset
4
onset uveitis
4

Similar Publications

Behçet's disease is a kind of variable vessel vasculitis (VVV) and inflammatory systematic disease affecting various organs of the body. The cause of the disease is idiopathic but is most commonly genetic in origin. A positive skin prick test (dermatographia), genital sores, eye irritation, skin sores, and at least three episodes of mouth sores in a year confirm the diagnosis.

View Article and Find Full Text PDF

We herein report intraocular inflammation (IOI) following intravitreal (IVT) faricimab injection in three patients. A 73-year-old male, a 68-year-old female, and an 82-year-old female, all diagnosed with neovascular age-related macular degeneration (AMD), had received multiple anti-vascular endothelial growth factor (anti-VEGF) injections for the same. They were injected with IVT faricimab due to non-response to other agents.

View Article and Find Full Text PDF

Neuro-Behcet's Masquerading as Status Epilepticus and Meningoencephalitis in the Emergency Department.

J Emerg Med

October 2024

Department of Emergency Medicine, Cleveland Clinic Akron General, Akron, Ohio; Northeast Ohio Medical University, Rootstown, Ohio. Electronic address:

Background: Behcet disease (BD) is a rare small vessel vasculitis that commonly manifests as recurrent painful oral or genital ulcerations, uveitis, and skin lesions. Some patients with BD develop neurological symptoms termed neuro-Behcet's disease. In the emergency department setting, these symptoms can be mistaken for other common acute issues including stroke, infection, epilepsy, multiple sclerosis, toxin ingestion, or psychiatric conditions.

View Article and Find Full Text PDF

Purpose: To investigate ocular manifestation of immune reconstitution inflammatory syndrome (IRIS) in human immunodeficiency virus (HIV) patients after starting highly active antiretroviral therapy (HAART) and its relationship to T cell immunity.

Methods: HIV patients with ocular IRIS after HAART were retrospectively reviewed. Clinical presentations with previous opportunistic infection, duration from initiation of HAART to IRIS, blood CD4+, CD8+ T cell count, and HIV RNA copies before HAART and at IRIS were analyzed.

View Article and Find Full Text PDF

The Role of Ageing in the Clinical Presentation of Uveitis.

Am J Ophthalmol

January 2025

Te Whatu Ora Te Toka Tumai/Health New Zealand Auckland, Auckland, New Zealand; University of Auckland, Auckland, New Zealand.

Purpose: The primary aim of this study was to determine age-related patterns of uveitis entities. Secondary aims included age-related patterns of uveitic treatments and complications.

Design: Retrospective clinical cohort study Methods: 4,395 participants presenting with uveitis to a single center from January 2009 to December 2023 were included.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!